Available studies revealed that OMT attenuated hepatic steatosis through the down-regulation of sterol regulatory element binding transcription factor 1 (SREBF1) and up-regulation of peroxisome proliferator activated receptor alpha (PPARα) mediated metabolic pathway (Shi L.J. et al., 2013). Here, SREBF1 is linked to fatty liver disease.